This inventor holds 5 USPTO granted patents and 1 EPO patent. Top assignees: Cornell University, Memorial Sloan Kettering Cancer Center. Active years: 2017-2024.
Company Filing History:
5 out of 2,948 
2 out of 618 
Years Active: 2017-2024
Certainly! Here is the article about inventor Martin J Hicks:
Title: Inventor Spotlight: Martin J Hicks
Introduction:
Martin J Hicks, a prolific inventor based in New York, NY, has made significant contributions to the field of biomedical research through his innovative patents.
Latest Patents:
1. "Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodies": This patent focuses on inhibiting or treating brain cancers by locally inhibiting the expression or activity of growth factors or growth factor receptors.
2. "AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessation": This invention involves an adeno-associated virus (AAV) vector containing a nucleic acid sequence encoding an antibody that binds to nicotine, aiming to induce an immune response against nicotine in mammals.
Career Highlights:
Martin Hicks has accumulated a total of 4 patents throughout his career, showcasing his dedication to pioneering medical advancements.
Collaborations:
During his tenure, Hicks has collaborated with esteemed professionals such as Ronald G Crystal and Bishnu P De. He has lent his expertise to reputable institutions including Cornell University and the Memorial Sloan Kettering Cancer Center.
Conclusion:
Martin J Hicks' groundbreaking inventions in the realm of biomedical science exemplify his commitment to driving innovation and addressing critical healthcare challenges. His collaborative efforts and patent portfolio stand as a testament to his remarkable contributions to the scientific community.